The In Vitro Diagnostics (IVD) Market is a critical sector dedicated to the testing of biological samples (blood, urine, tissues) outside the body to detect diseases, monitor patient health, and select appropriate therapies.

Secondly, Point-of-Care Testing (POCT) is gaining immense traction, leveraging miniaturized, portable devices (like rapid antigen tests) to deliver diagnostic results quickly at the patient's bedside, pharmacy, or home, accelerating clinical decision-making and democratizing access to testing across the In Vitro Diagnostics (IVD) Market.

Market growth is being fueled by the rising global prevalence of chronic and infectious diseases, coupled with a fundamental shift toward precision medicine.

Two major technological trends dominate the market landscape. Firstly, Molecular Diagnostics, including Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR), is expanding rapidly, providing highly sensitive and specific tools for detecting genetic markers, cancer mutations, and infectious pathogens.

Related Reports